Cozaar: Clinical Trials

17 trials of Cozaar, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated, 3 active not recruiting, 1 recruiting. 17 Phase 2, 3 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 217Completed 7, Terminated 4, Active not recruiting 3, Recruiting 1, Suspended 1, Unknown 1
Phase 13Completed 1, Suspended 1, Terminated 1
Phase 32Terminated 1, Unknown 1

Follow Cozaar: new trials by email Literature Review of Cozaar trials Research Report on Cozaar

Trials (filtered) newest first · largest first

All 17 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer
FOLFIRNINOX, Losartan, 9-ING-41 - Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic
Phase 2Active not recruitingColin D. Weekes, M.D., PhD702022-03-212026-09-11
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer
Capecitabine, Fluorouracil, Irinotecan Hydrochloride - Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8
Phase 2Active not recruitingOHSU Knight Cancer Institute422021-05-272026-01-14
Losartan for Patients With COVID-19 Requiring Hospitalization
Losartan, Placebo - Corona Virus Infection, Acute Respiratory Distress Syndrome
Phase 2CompletedUniversity of Minnesota2052020-04-132022-06-29
Losartan for Patients With COVID-19 Not Requiring Hospitalization
Losartan, Placebo - Corona Virus Infection, Acute Respiratory Distress Syndrome
Phase 2CompletedUniversity of Minnesota1172020-04-092022-05-04
COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19
Losartan, Placebo - SARS-CoV-2 Infection
Phase 2 / Phase 3TerminatedBassett Healthcare152020-04-062022-03-24
Chinese Medicine Treat for Hypertensive Renal Injury
Losartan 100Mg Tab, Qianyangyuyin 20g Granule, placebo - Hypertension, Renal Injury
Phase 2 / Phase 3UnknownJiangsu Province Hospital of Traditional Chinese Medicine5202019-09-102019-09-06
Losartan and Inflammation in Cystic Fibrosis
Losartan, placebo - Cystic Fibrosis
Phase 2TerminatedUniversity of Miami72017-11-112020-11-27
Pilot Trial: the Safety and Feasibility of Losartan for Pulmonary Vein Stenosis
Losartan - Pulmonary Vein Stenosis, Children
Phase 1 / Phase 2SuspendedThe Hospital for Sick Children402016-05-012019-07-30
The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study
Omega-3 fish oil, Losartan, Corn Oil (Fish oil Placebo) - Inflammation
Phase 2CompletedUniversity of Florida2892016-04-262024-05-07
Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV
Microneurography, Combat virtual reality video clip, Handgrip Exercise - Stress Disorders, Post-Traumatic
Phase 2RecruitingEmory University1342015-10-012026-05-18
Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV
Losartan, Placebo - HIV Infection, HIV Infections
Phase 2CompletedUniversity of Minnesota522014-09-012020-12-11
Study of Losartan in the Treatment of NAFLD in Children
Losartan - NAFLD
Phase 2CompletedMiriam Vos, MD122013-07-012017-05-15
Pilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in Elderly
N-acetylcysteine, Losartan, Placebo losartan - Aging
Phase 1 / Phase 2CompletedThe University of Texas Medical Branch, Galveston62011-07-012018-05-08
Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
Fractionated proton radiation, Losartan - Vestibular Schwannoma, Acoustic Neuroma
Phase 2Active not recruitingMassachusetts General Hospital302011-03-082026-09-11
Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors
lisinopril, losartan potassium, laboratory biomarker analysis - Hypertension, Unspecified Adult Solid Tumor, Protocol Specific
Phase 2TerminatedWake Forest University Health Sciences62011-02-012018-08-28
Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak Syndrome
Losartan, Zileuton, N-Acetylcysteine - Hermansky-Pudlak Syndrome (HPS), Pulmonary Fibrosis
Phase 1 / Phase 2TerminatedNational Human Genome Research Institute (NHGRI)32007-04-012013-08-02
Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy
losartan, placebo - Hypertrophic Cardiomyopathy
Phase 2CompletedMassachusetts General Hospital202007-02-012013-09-05

Conditions studied

COVID-19 (3)  ·  Coronavirus Infections (3)  ·  Hypertension (2)  ·  Respiratory Distress Syndrome (2)  ·  Severe Acute Respiratory Syndrome (2)  ·  Albinism (1)  ·  Albinism, Oculocutaneous (1)  ·  Cardiomyopathy, Hypertrophic (1)  ·  Cystic Fibrosis (1)  ·  Fibrosis (1)  ·  HIV Infections (1)  ·  Hermanski-Pudlak Syndrome (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Lung Diseases (1)

Sponsors

University of Minnesota (3)  ·  Massachusetts General Hospital (2)  ·  Bassett Healthcare (1)  ·  Colin D. Weekes, M.D., PhD (1)  ·  Emory University (1)  ·  Jiangsu Province Hospital of Traditional Chinese Medicine (1)  ·  Miriam Vos, MD (1)  ·  National Human Genome Research Institute (NHGRI) (1)  ·  OHSU Knight Cancer Institute (1)  ·  The Hospital for Sick Children (1)  ·  The University of Texas Medical Branch, Galveston (1)  ·  University of Florida (1)  ·  University of Miami (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (15)  ·  Canada (1)

Top investigators

Christopher Tignanelli, MD (2)  ·  Michael Puskarich, MD, MS (2)  ·  Astrid M Horstman, PhD (1)  ·  Charles D Lopez (1)  ·  Christopher A Caldarone, MD (1)  ·  Colin D Weekes, MD, PhD (1)  ·  Daniel Freilich, MD (1)  ·  Helen A. Shih, MD (1)  ·  Jeanie Park, MD (1)  ·  Marco Pahor, MD (1)  ·  Matthias Salathe, MD (1)  ·  Melinda Sheffield-Moore, PhD (1)  ·  Michael A Fifer, MD (1)  ·  Ming Liu (1)  ·  Miriam Vos, MD, MSPH (1)

Results publications

PMID 32658300, PMID 24621999, PMID 29992039, PMID 30541065, PMID 34195577, PMID 34473343, PMID 35229827, PMID 35294537

NIH funding

R03DK096157 (1), U01AG050499 (1), U01AI105872 (1)